Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PharmaLogic Consulting AB
AB
Active
Org 5569205056
Granvägen 4 A, 191 41
Sollentuna
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2013
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
PharmaLogic Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
3M
4M
6M
3M
2021
0M
2022
5M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
1M
2M
3M
3M
2M
2021
-1M
2022
3M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
2 738
206
4 696
230
0
Staff expenses
—
−549
−592
−0
−14
EBITDA
1 757
−1 042
3 499
−74
−50
Depreciation & amort.
−0
—
—
—
—
EBIT
1 757
−994
3 499
−74
−50
Net financials
—
−226
98
144
−31
Profit before tax
1 606
−330
5 445
132
−25
Tax
−351
−351
−1 129
—
—
Net profit
1 255
−330
4 315
132
−25
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
10 337
8 855
10 181
9 919
8 697
Equity
7 022
6 371
8 686
8 718
8 693
Long-term debt
0
—
—
—
—
Short-term debt
278
336
1 194
1 012
4
Total debt
278
336
1 194
1 012
4
Financial ratios
5-year trend
EBITDA margin
-4996500.0%
This company
15.8%
Market median
-31623518% vs market
2021
2025
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
2021
2025
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
2021
2025
Net profit margin
-2542700.0%
This company
8.1%
Market median
-31391458% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
View
PDF
More on PharmaLogic Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
